ATB-263 and ATB-199 inhibit/block Bcl-2 for Advanced hematological cancers and CLL 73,74 and MIM1 which inhibits Mcl-1 in clinical trials.126. The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.